Transthyretin: More than meets the eye

Progress in Neurobiology

Volumn 89, Issue 3, 2009, Pages 266-276

  Fleming, Carolina Estima ^a   Nunes, Ana Filipa ^a   Sousa, Mónica Mendes ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Alzheimer's disease; Disease biomarkers; Protein profile analysis; Transthyretin; TTR KO mice

Indexed keywords

ALPHA AMIDATING ENZYME; APOLIPOPROTEIN A1; BIOLOGICAL MARKER; BRINASE; CELLULAR RETINOL BINDING PROTEIN 1; LIPOPROTEIN; LIPOPROTEIN LIPASE; NEUROPEPTIDE Y; NORADRENALIN; PLASMA PROTEIN; PREALBUMIN; PROTEINASE; RETINOL; RETINOL BINDING PROTEIN; THYROID HORMONE; THYROXINE; THYROXINE BINDING GLOBULIN; THYROXINE BINDING PROTEIN;

ALZHEIMER DISEASE; AUTONOMIC DYSFUNCTION; DEGENERATIVE DISEASE; DEPRESSION; FAMILIAL AMYLOID POLYNEUROPATHY; GUILLAIN BARRE SYNDROME; HORMONE METABOLISM; HUMAN; KNOCKOUT MOUSE; LIPOPROTEIN METABOLISM; MEMORY DISORDER; MENTAL PERFORMANCE; MUTATION; NERVE REGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; POLYNEUROPATHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; PSYCHOSIS; RETINOL DEFICIENCY; REVIEW; SENSORIMOTOR FUNCTION; VITAMIN METABOLISM;

AMYLOID BETA-PROTEIN; ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MENTAL DISORDERS; MICE; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; PREALBUMIN;

EID: 70350302639     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2009.07.007     Document Type: Review

References (107)

1. Abram S.R., Kruskal J.B., Allen G.S., Burns R.S., Parker R., and Tulipan N. Alterations in prealbumin concentration after adrenal autotransplantation for Parkinson's disease. Exp. Neurol. 108 (1990) 130-135
2. Aleshire S.L., Bradley C.A., Richardson L.D., and Parl F.F. Localization of human prealbumin in choroid plexus epithelium. J. Histochem. Cytochem. 31 (1983) 608-612
3. Andersson K., Olofsson A., Nielsen E.H., Svehag S.E., and Lundgren E. Only amyloidogenic intermediates of transthyretin induce apoptosis. Biochem. Biophys. Res. Commun. 294 (2002) 309-314
4. Andrade C. A peculiar form of peripheral neuropathy. Familial atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 75 (1952) 408-427
5. Biesiada E., Adams P.M., Shanklin D.R., Bloom G.S., and Stein S.A. Biology of the congenitally hypothyroid hyt/hyt mouse. Adv. Neuroimmunol. 6 (1996) 309-346
6. Bitan G., Kirkitadze M.D., Lomakin A., Vollers S.S., Benedek G.B., and Teplow D.B. Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 330-335
7. Blake C.C., Geisow M.J., Swan I.D., Rerat C., and Rerat B. Structure of human plasma prealbumin at 2.5 Å resolution. A preliminary report on the polypeptide chain conformation, quaternary structure and thyroxine binding. J. Mol. Biol. 88 (1974) 1-12
8. Bonifacio M.J., Sakaki Y., and Saraiva M.J. 'In vitro' amyloid fibril formation from transthyretin, the influence of ions and the amyloidogenicity of TTR variants. Biochim. Biophys. Acta 1316 (1996) 35-42
9. Brouillette J., and Quirion R. Transthyretin: a key gene involved in the maintenance of memory capacities during aging. Neurobiol. Aging 29 (2008) 1721-1732
10. Bui B.V., Armitage J.A., Fletcher E.L., Richardson S.J., Schreiber G., and Vingrys A.J. Retinal anatomy and function of the transthyretin null mouse. Exp. Eye Res. 73 (2001) 651-659
11. Buxbaum J.N., Ye Z., Reixach N., Friske L., Levy C., et al. Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity. Proc. Natl. Acad. Sci. U.S.A. 105 (2008) 2681-2686
12. Cardoso I., Goldsbury C.S., Müller S.A., Olivieri V., Wirtz S., et al. Transthyretin fibrillogenesis entails the assembly of monomers: A molecular model for in vitro assembled transthyretin amyloid-like fibrils. J. Mol. Biol. 317 (2002) 687-699
13. Carro E., Trejo J.L., Gomez-Isla T., LeRoith D., and Torres-Aleman I. Serum insulin-like growth factor I regulates brain amyloid-beta levels. Nat. Med. 8 (2002) 1390-1397
14. Castaño E.M., Roher A.E., Esh C.L., Kokjohn T.A., and Beach T. Comparative proteomics of cerebrospinal fluid in neuropathologically-confirmed Alzheimer's disease and non-demented elderly subjects. Neurol. Res. 28 (2006) 155-163
15. Choi S.H., Leight S.N., Lee V.M., Li T., Wong P.C., et al. Accelerated Abeta deposition in APPswe/PS1deltaE9 mice with hemizygous deletions of TTR (transthyretin). J. Neurosci. 27 (2007) 7006-7010
16. Costa P.P., Figueira A.S., and Bravo F.R. Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 4499-4503
17. Costa R., Gonçalves A., Saraiva M.J., and Cardoso I. Transthyretin binding to A-Beta peptide-impact on A-Beta fibrillogenesis and toxicity. FEBS Lett. 582 (2008) 936-942
18. Costa R., Ferreira-da-Silva F., Saraiva M.J., and Cardoso I. Transthyretin protects against A-beta peptide toxicity by proteolytic cleavage of the peptide: a mechanism sensitive to the Kunitz protease inhibitor. PLoS ONE 3 (2008) e2899
19. D'Aguanno S., Barassi A., Lupisella S., d'eril G.M., Del Boccio P., et al. Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis. J. Neuroimmunol. 193 (2008) 156-160
20. Elovaara I., Maury C.P., and Palo J. Serum amyloid A protein, albumin and prealbumin in Alzheimer's disease and in demented patients with Down's syndrome. Acta Neurol. Scand. 74 (1986) 245-250
21. Episkopou V., Maeda S., Nishiguchi S., Shimada K., Gaitanaris G.A., et al. Disruption of the transthyretin gene results in mice with depressed levels of plasma retinol and thyroid hormone. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 2375-2379
22. Ewald H., Mors O., Koed K., Eiberg H., and Kruse T.A. Susceptibility loci for bipolar affective disorder on chromosome 18? A review and a study of Danish families. Psychiatr. Genet. 7 (1997) 1-12
23. Fleming C.E., Saraiva M.J., and Sousa M.M. Transthyretin enhances nerve regeneration. J. Neurochem. 103 (2007) 831-839
24. Fleming C.E., Mar F.M., Franquinho F., Saraiva M.J., and Sousa M.M. Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity. J. Neurosci. 29 (2009) 3220-3232
25. Fuhrman M.P., Charney P., and Mueller C.M. Hepatic proteins and nutrition assessment. J. Am. Diet. Assoc. 104 (2004) 1258-1264
26. Furtado L., Oliveira F., Furtado E., Geraldes B., Reis A., et al. Maximum sharing of cadaver liver grafts composite split and domino liver transplants. Liver Transpl. Surg. 5 (1999) 157-158
27. Gloeckner S.F., Meyne F., Wagner F., Heinemann U., Krasnianski A., et al. Quantitative analysis of transthyretin, tau and amyloid-beta in patients with dementia. J. Alzheimers Dis. 14 (2008) 17-25
28. Gonçalves I., Alves C.H., Quintela T., Baltazar G., Socorro S., et al. Transthyretin is up-regulated by sex hormones in mice liver. Mol. Cell. Biochem. 317 (2008) 137-142
29. Hagen G.A., and Solberg Jr. L.A. Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology 95 (1974) 1398-1410
30. Hansson S.F., Puchades M., Blennow K., Sjögren M., and Davidsson P. Validation of a prefractionation method followed by 2-dimensional electrophoresis-applied to cerebrospinal fluid proteins from frontotemporal dementia patients. Proteome Sci. 2 (2004) 7
31. Harms P.J., Tu G.F., Richardson S.J., Aldred A.R., Jaworowski A., and Schreiber G. Transthyretin (prealbumin) gene expression in choroid plexus is strongly conserved during evolution of vertebrates. Comp. Biochem. Physiol. B 99 (1991) 239-249
32. Hatterer J.A., Herbert J., Hidaka C., Roose S.P., and Gorman J.M. CSF transthyretin in patients with depression. Am. J. Psychiatry 150 (1993) 813-815
33. Heilig M. The NPY system in stress, anxiety and depression. Neuropeptides 38 (2004) 213-224
34. Holmgren G., Ericzon B.G., Groth C.G., Steen L., Suhr O., et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341 (1993) 1113-1116
35. Hou X., Aguilar M.I., and Small D.H. Transthyretin and familial amyloidotic polyneuropathy. Recent progress in understanding the molecular mechanism of neurodegeneration. FEBS J. 274 (2007) 1637-1650
36. Huang J.T., Leweke F.M., Oxley D., Wang L., Harris N., et al. Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med. 3 (2006) e428
37. Ingenbleek Y., De Visscher M., and De Nayer P. Measurement of prealbumin as index of protein-calorie malnutrition. Lancet 2 (1972) 106-109
38. Ingenbleek Y., and Young V.R. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu. Rev. Nutr. 14 (2002) 495-533
39. Jin T., Hu L.S., Chang M., Wu J., Winblad B., and Zhu J. Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients. Eur. J. Neurol. 14 (2007) 563-568
40. Johnson A.M., Merlini G., Sheldon J., and Ichihara K. Clinical indications for plasma protein assays, transthyretin (prealbumin) in inflammation and malnutrition. Clin. Chem. Lab. Med. 45 (2007) 419-426
41. Jorgensen O.S. Neural cell adhesion molecule (NCAM) and prealbumin in cerebrospinal fluid from depressed patients. Acta Psychiatr. Scand. Suppl. 345 (1988) 29-37
42. Kajiwara K., Sunaga K., Tsuda T., Sugaya A., Sugaya E., and Kimura M. Peony root extract upregulates transthyretin and phosphoglycerate mutase in mouse cobalt focus seizure. Biochem. Biophys. Res. Commun. 371 (2008) 375-379
43. Kassem N.A., Deane R., Segal M.B., and Preston J.E. Role of transthyretin in thyroxine transfer from cerebrospinal fluid to brain and choroid plexus. Am. J. Physiol. Regul. Integr. Comp. Physiol. 291 (2006) R1310-R1315
44. Kawaguchi R., Yu J., Honda J., Hu J., Whitelegge J., et al. A membrane receptor for retinol binding protein mediates cellular uptake of vitamin A. Science 315 (2007) 820-825
45. Kohda K., Jinde S., Iwamoto K., Bundo M., Kato N., and Kato T. Maternal separation stress drastically decreases expression of transthyretin in the brains of adult rat offspring. Int. J. Neuropsychopharmacol. 9 (2006) 201-208
46. Lazarov O., Robinson J., Tang Y.P., Hairston I.S., Korade-Mirnics Z., et al. Environmental enrichment reduces Abeta levels and amyloid deposition in transgenic mice. Cell 120 (2005) 701-713
47. Lehmensiek V., Süssmuth S.D., Brettschneider J., Tauscher G., Felk S., et al. Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS). J. Neuroimmunol. 185 (2007) 190-194
48. Lein E.S., Hawrylycz M.J., Ao N., Ayres M., Bensinger A., et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445 (2007) 168-176
49. Liu L., and Murphy R.M. Kinetics of inhibition of beta-amyloid aggregation by transthyretin. Biochemistry 45 (2006) 15702-15709
50. Liz M.A., Faro C.J., Saraiva M.J., and Sousa M.M. Transthyretin, a new cryptic protease. J. Biol. Chem. 279 (2004) 21431-21438
51. Liz M.A., Gomes C.M., Saraiva M.J., and Sousa M.M. ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity. J. Lipid Res. 48 (2007) 2385-2395
52. Liz M.A., Fleming C.E., Nunes A.F., Almeida M.R., Mar F.M., Choe Y., Craik C.S., Powers J.C., Bogyo M., and Sousa M.M. Substrate specificity of transthyretin: identification of natural substrates in the nervous system. Biochem. J. 419 (2009) 467-474
53. Maeda S., Mita S., Araki S., and Shimada K. Structure and expression of the mutant prealbumin gene associated with familial amyloidotic polyneuropathy. Mol. Biol. Med. 3 (1986) 329-338
54. Matsuoka T., Tsunoda M., Sumiyoshi T., Takasaki I., Tabuchi Y., Seo T., Tanaka K., Uehara T., Itoh H., Suzuki M., and Kurachi M. Effect of MK-801 on gene expressions in the amygdala of rats. Synapse 62 (2008) 1-7
55. Merched A., Serot J.M., Visvikis S., Aguillon D., Faure G., and Siest G. Apolipoprotein E, transthyretin and actin in the CSF of Alzheimer's patients, relation with the senile plaques and cytoskeleton biochemistry. FEBS Lett. 425 (1998) 225-228
56. Murakami T., Ohsawa Y., and Sunada Y. The transthyretin gene is expressed in human and rodent dorsal root ganglia. Neurosci. Lett. 436 (2008) 335-339
57. Nunes A.F., Saraiva M.J., and Sousa M.M. Transthyretin knockouts are a new mouse model for increased neuropeptide Y. FASEB J. 20 (2006) 166-168
58. Palha J.A., Episkopou V., Maeda S., Shimada K., Gottesman M.E., and Saraiva M.J. Thyroid hormone metabolism in a transthyretin-null mouse strain. J. Biol. Chem. 269 (1994) 33135-33139
59. Palha J.A., Hays M.T., Morreale de Escobar G., Episkopou V., Gottesman M.E., and Saraiva M.J. Transthyretin is not essential for thyroxine to reach the brain and other tissues in transthyretin-null mice. Am. J. Physiol. 272 (1997) E485-493
60. Palha J.A., Fernandes R., de Escobar G.M., Episkopou V., Gottesman M., and Saraiva M.J. Transthyretin regulates thyroid hormone levels in the choroid plexus, but not in the brain parenchyma: study in a transthyretin-null mouse model. Endocrinology 141 (2000) 3267-3272
61. Palha J.A. Transthyretin as a thyroid hormone carrier, function revisited. Clin. Chem. Lab. Med. 40 (2002) 1292-1300
62. Prigge S.T., Mains R.E., Eipper B.A., and Amzel L.M. New insights into copper monooxygenases and peptide amidation: structure, mechanism and function. Cell. Mol. Life Sci. 57 (2000) 1236-1259
63. Pulford D.J., Adams F., Henry B., Mallinson D.J., Reid I.C., and Stewart C.A. Chronic lithium administration down regulates transthyretin mRNA expression in rat choroid plexus. Neuropsychiatric Dis. Treat. 2 (2006) 549-555
64. Qian X., Samadani U., Porcella A., and Costa R.H. Decreased expression of hepatocyte nuclear factor 3 alpha during the acute-phase response influences transthyretin gene transcription. Mol. Cell. Biol. 15 (1995) 1364-1376
65. Quintas A., Vaz D.C., Cardoso I., Saraiva M.J., and Brito R.M. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J. Biol. Chem. 276 (2001) 27207-27213
66. Raguso C.A., Genton L., Dupertuis Y.M., and Pichard C. Assessment of nutritional status in organ transplant: is transthyretin a reliable indicator?. Clin. Chem. Lab. Med. 40 (2002) 1325-1328
67. Raz A., and Goodman D.S. The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex. J. Biol. Chem. 244 (1969) 3230-3237
68. Richardson S.J., Lemkine G.F., Alfama G., Hassani Z., and Demeneix B.A. Cell division and apoptosis in the adult neural stem cell niche are differentially affected in transthyretin null mice. Neurosci. Lett. 421 (2007) 234-238
69. Riisoen H. Reduced prealbumin (transthyretin) in CSF of severely demented patients with Alzheimer's disease. Acta Neurol. Scand. 78 (1988) 455-459
70. Rite I., Argüelles S., Venero J.L., García-Rodriguez S., Ayala A., et al. Proteomic identification of biomarkers in the cerebrospinal fluid in a rat model of nigrostriatal dopaminergic degeneration. J. Neurosci. Res. 85 (2007) 3607-3618
71. Robbins J. Thyroid hormone transport proteins and the physiology of hormone binding. In: Braverman L.E., and Utiger R.D. (Eds). The Thyroid (1991), JB Lippincott Company, Philadelphia 111-125
72. Ruano D., Macedo A., Soares M.J., Valente J., Azevedo M.H., et al. Transthyretin, no association between serum levels or gene variants and schizophrenia. J. Psychiatr. Res. 41 (2007) 667-672
73. Rüetschi U., Zetterberg H., Podust V.N., Gottfries J., Li S., et al. Identification of CSF biomarkers for frontotemporal dementia using SELDI-TOF. Exp. Neurol. 196 (2005) 273-281
74. Saraiva M.J., Birken S., Costa P.P., and Goodman D.S. Amyloid fibril protein in familial amyloidotic polyneuropathy. Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin). J. Clin. Invest. 74 (1984) 104-119
75. Saraiva M.J. Transthyretin mutations in hyperthyroxinemia and amyloid diseases. Hum. Mutat. 17 (2001) 493-503
76. Schreiber G., Pettersson T.M., Southwell B.R., Aldred A.R., Harms P.J., et al. Transthyretin gene expression evolved more recently in the liver than in the brain. Comp. Biochem. Physiol. 105B (1993) 317-325
77. Schultz K., Träskman-Bendz L., and Petersén A. Transthyretin in cerebrospinal fluid from suicide attempters. J. Affect. Disord. 109 (2008) 205-208
78. Schwarzman A.L., Gregory L., Vitek M.P., Lyubski S., Strittmatter W., et al. Transthyretin sequesters amyloid β protein and prevents amyloid formation. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 8368-8372
79. Schwarzman A.L., Tsiper M., Wente H., Wang A., Vitek M.P., Vasiliev V., and Goldgaber D. Amyloidogenic and anti-amyloidogenic properties of recombinant transthyretin variants. Amyloid 11 (2004) 1-9
80. Sebastiao M.P., Saraiva M.J., and Damas A.M. The crystal structure of amyloidogenic Leu55 -> Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J. Biol. Chem. 273 (1998) 24715-247122
81. Serot J.M., Christmann D., Dubost T., and Couturier M. Cerebrospinal fluid transthyretin: aging and late onset Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 63 (1997) 506-508
82. Smith A.M., Bowers B.J., Radcliffe R.A., and Wehner J.M. Microarray analysis of the effects of a gamma-protein kinase C null mutation on gene expression in striatum, a role for transthyretin in mutant phenotypes. Behav. Genet. 36 (2006) 869-881
83. Sousa J.C., Grandela C., Fernandez-Ruiz J., de Miguel R., de Sousa L., et al. Transthyretin is involved in depression-like behaviour and exploratory activity. J. Neurochem. 88 (2004) 1052-1058
84. Sousa J.C., Marques F., Dias-Ferreira E., Cerqueira J.J., Sousa N., and Palha J.A. Transthyretin influences spatial reference memory. Neurobiol. Learn. Mem. 88 (2007) 381-385
85. Sousa J.C., Cardoso I., Marques F., Saraiva M.J., and Palha J.A. Transthyretin and Alzheimer's disease: where in the brain?. Neurobiol. Aging 28 (2007) 713-718
86. Sousa M.M., and Saraiva M.J. Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling. Prog. Neurobiol. 71 (2003) 385-400
87. Sousa M.M., Berglund L., and Saraiva M.J. Transthyretin in high density lipoproteins, association with apolipoprotein A-I. J. Lipid Res. 41 (2000) 58-65
88. Sousa M.M., Cardoso I., Fernandes R., Guimarães A., and Saraiva M.J. Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregates. Am. J. Pathol. 159 (2001) 1993-2000
89. Sousa M.M., and Saraiva M.J. Transthyretin is not expressed by dorsal root ganglia cells. Exp. Neurol. 214 (2008) 362-365
90. Stein T.D., and Johnson J.A. Genetic programming by the proteolytic fragments of the amyloid precursor protein: somewhere between confusion and clarity. Rev. Neurosci. 14 (2003) 317-341
91. Stein T.D., Anders N.J., DeCarli C., Chan S.L., Mattson M.P., and Johnson J.A. Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSW mice resulting in tau phosphorylation and loss of hippocampal neurons, support for the amyloid hypothesis. J. Neurosci. 24 (2004) 7707-7717
92. Sullivan G.M., Hatterer J.A., Herbert J., Chen X., Roose S.P., Attia E., et al. Low levels of transthyretin in the CSF of depressed patients. Am. J. Psychiatry 156 (1999) 710-715
93. Sullivan G.M., Mann J.J., Oquendo M.A., Lo E.S., Cooper T.B., and Gorman J.M. Low cerebrospinal fluid transthyretin levels in depression, correlations with suicidal ideation and low serotonin function. Biol. Psychiatry 60 (2006) 500-506
94. Sundaram M., Sivaprasadarao A., Sousa M.M., and Findlay J.B. The transfer of retinol from serum retinol-binding protein to cellular retinol-binding protein is mediated by a membrane receptor. J. Biol. Chem. 273 (1998) 3336-3342
95. Suzuyama K., Shiraishi T., Oishi T., Ueda S., Okamoto H., et al. Combined proteomic approach with SELDI-TOF-MS and peptide mass fingerprinting identified the rapid increase of monomeric transthyretin in rat cerebrospinal fluid after transient focal cerebral ischemia. Brain Res. Mol. Brain Res. 129 (2004) 44-53
96. Tanaka Y., Ando Y., Kumamoto T., Miyazaki A., Nakamura M., et al. Changed affinity of apolipoprotein AII to high density lipoproteins in patients with familial amyloidotic polyneuropathy (FAP) type I. Biochim. Biophys. Acta 1225 (1996) 311-316
97. Tang Y.P., Haslam S.Z., Conrad S.E., and Sisk C.L. Estrogen increases brain expression of the mRNA encoding transthyretin, an amyloid beta scavenger protein. J. Alzheimers Dis. 6 (2004) 413-420
98. Teng M.H., Yin J.Y., Vidal R., Ghiso J., Kumar A., et al. Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis. Lab. Invest. 81 (2001) 385-396
99. Uversky V.N. A protein-chameleon: conformational plasticity of alpha-synuclein, a disordered protein involved in neurodegenerative disorders. J. Biomol. Struct. Dyn. 21 (2003) 211-234
100. Wan C., Yang Y., Li H., La Y., Zhu H., et al. Dysregulation of retinoid transporters expression in body fluids of schizophrenia patients. J. Proteome Res. 5 (2006) 3213-3216
101. Wati H., Kawarabayashi T., Matsubara E., Kasai A., Hirasawa T., et al. Transthyretin accelerates vascular abeta deposition in a mouse model of Alzheimer's disease. Brain Pathol. 19 (2008) 48-57
102. Weeke B., and Jarnum S. Serum concentration of 19 serum proteins in Crohn's disease and ulcerative colitis. Gut 12 (1971) 297-302
103. Wei S., Episkopou V., Piantedosi R., Maeda S., Shimada K., et al. Studies on the metabolism of retinol and retinol-binding protein in transthyretin-deficient mice produced by homologous recombination. J. Biol. Chem. 270 (1995) 866-870
104. Wu Z.L., Ciallella J.R., Flood D.G., O'Kane T.M., Bozyczko-Coyne D., and Savage M.J. Comparative analysis of cortical gene expression in mouse models of Alzheimer's disease. Neurobiol. Aging 27 (2006) 377-386
105. Yang Y., Wan C., Li H., Zhu H., La Y., et al. Altered levels of acute phase proteins in the plasma of patients with schizophrenia. Anal. Chem. 78 (2006) 3571-3576
106. Yang Y.R., Liu S.L., Qin Z.Y., Liu F.J., Qin Y.J., et al. Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome. Cell. Mol. Neurobiol. 28 (2008) 737-744
107. Zapala M.A., Hovatta I., Ellison J.A., Wodicka L., Del Rio J.A., et al. Adult mouse brain gene expression patterns bear an embryologic imprint. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 10357-10362